Voriconazole, a second-generation triazole, has recently been approved by the Food and Drug Administration (FDA) to treat invasive aspergillosis and refractory infections with Scedosporium apiospermum or Fusarium spp. The reported side-effects of voriconazole include visual changes, headaches, elevated hepatic enzymes, Steven-Johnson syndrome, toxic epidermal necrolysis, chelitis, photosensitivity, discoid lupus erythematosus and anaphylactoid infusion reactions. Pseudoporphyria was first described in association with nalidixic acid. It has the same clinical and histologic features as porphyria cutanea tarda (PCT) but is distinguished by normal porphyrin levels in the serum, urine and stool. We present the case of a patient who developed pseudoporphyria after receiving treatment with voriconazole.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1365-4632.2004.02177.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Drug-associated porphyria: a pharmacovigilance study.
Orphanet J Rare Dis
August 2024
Department of Pharmacy, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Article Synopsis
- * Researchers analyzed ADRs related to porphyria from January 2004 to March 2022 and narrowed down 406 drugs, ultimately identifying 52 drugs associated with adverse effects using various statistical algorithms.
- * The findings provide essential insights into the safety of drugs for porphyria carriers, helping healthcare providers make informed decisions and avoid prescribing harmful medications.
Article Synopsis
- - The goal of the educational activity is to enhance understanding of how pseudoporphyria manifests in patients.
- - It's aimed at healthcare professionals like doctors and nurses who focus on skin and wound care.
- - Participants will learn to recognize pseudoporphyria's symptoms, differentiate it from other conditions that cause blistering, and understand treatment options.
Drug-Induced Photosensitivity: Clinical Types of Phototoxicity and Photoallergy and Pathogenetic Mechanisms.
Front Allergy
June 2022
Department of Clinical and Experimental Medicine, Dermatology, University of Messina, Messina, Italy.
Drug-induced photosensitivity (DIP) is a common cutaneous adverse drug reaction, resulting from the interaction of ultraviolet radiations, mostly ultraviolet A, with drugs. DIP includes phototoxicity and photoallergy. A phototoxic reaction is obtained when topical and systemic drugs or their metabolites absorb light inducing a direct cellular damage, while a photoallergic reaction takes place when the interaction between drugs and ultraviolet radiations causes an immune cutaneous response.
View Article and Find Full Text PDFBullous Amyloidosis Masquerading as Pseudoporphyria.
Cutis
September 2021
Dr. Darji is from the Department of Dermatology, Saint Louis University, Missouri. Dr. Butala is from the Dermatology Department, Lancaster Medical Offices, Kaiser Permanente, California. Drs. Manders and Green are from the Department of Dermatology, Cooper University Health Care, Camden, New Jersey.
Article Synopsis
- Amyloidosis encompasses a group of diseases related to abnormal protein folding, resulting in the formation of amyloid fibrils that can affect the skin, among other systems.
- Bullous amyloidosis, though rare, is a specific form that can be diagnosed through unique histopathologic and immunohistochemical patterns, distinguishing it from other skin conditions.
- Recognizing bullous amyloidosis is crucial, as it may indicate a more serious underlying condition, such as multiple myeloma or other lymphoproliferative disorders, which can impact treatment and management.
The Potential Uses of N-acetylcysteine in Dermatology: A Review.
J Clin Aesthet Dermatol
May 2019
Drs. May, Reservo, Tung, and Swan are with the Department of Dermatology at the Stritch School of Medicine at Loyola University Chicago in May wood, Illinois. Mses. Janeczek, Riopelle, and Vetter are with the Stritch School of Medicine at Loyola University Chicago in May wood, Illinois.
Article Synopsis
- * The review included a range of clinical studies published from 1966 to 2017, showcasing its efficacy in conditions like acne, excoriation disorder, and more.
- * Overall, N-acetylcysteine appears to be a safe and effective treatment option for numerous dermatological issues, including aiding in wound healing and protecting the skin.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!